FDA Advisers Recommend Next COVID-19 Vaccines Target XFG Variant

All but one adviser voted for the recommendation.

The U.S. Food and Drug Administration in White Oak, Md., on June 5, 2023. Madalina Vasiliu/The Epoch Times

The Food and Drug Administration’s panel of vaccine advisers on May 28 recommended that the next round of COVID-19 vaccines target the XFG COVID-19 variant.

Eight of the nine members of the Vaccines and Related Biological Products Advisory Committee who voted during a meeting said that the next vaccines should be monovalent, or only include one antigen, and that the preferred antigen is XFG.